Phibro Animal Health completed the acquisition of the medicated feed additive product portfolio of Zoetis from $350m.

Phibro Animal Health, an animal health and mineral nutrition company, completed the acquisition of the medicated feed additive product portfolio of Zoetis, a producer of medicine and vaccinations for pets and livestock, from $350m. “Adding this new lineup of medicated feed additives and water-soluble products across cattle, swine and poultry will complement and expand Phibro’s species and product portfolios, helping customers meet the highest standards of animal care, prevent disease, and enhance nutrition around the world. These products fit Phibro’s core competencies and capabilities while complementing our current lineup of vaccines, nutritional specialties and mineral nutrition,” Jack C. Bendheim, Phibro Animal Health Chairman, President and CEO.